1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Trabedersen: new trials by email Literature Review of Trabedersen trials Research Report on Trabedersen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma AP 12009 10 µM, AP 12009 80 µM, temozolomide or PCV - Glioblastoma, Anaplastic Astrocytoma | Phase 2 | Completed | Isarna Therapeutics GmbH | 141 | 2003-04-01 | 2013-12-03 |
Astrocytoma (1) · Brain Neoplasms (1) · Camurati-Engelmann Syndrome (1) · Glioblastoma (1) · Neoplasms (1)
Austria (1) · Georgia (1) · Germany (1) · India (1) · Israel (1) · Russia (1)